findmyKOL

Paul Pockros, MD

Enriched profile

Director, Liver Disease Center, Division of Gastroenterology/Hepatology, Scripps Clinic; Director of Clinical Research, Scripps Translational Science Institute · Scripps Clinic

ORCIDNPI
Region🇺🇸 La Jolla, CA · West · United StatesSpecialtyGastroenterologyFocusViral Hepatitis (B/C)
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceverified 2026Payments2021–2025NIH funding1987–2002

Paul Pockros is Director, Liver Disease Center, Division of Gastroenterology/Hepatology, Scripps Clinic; Director of Clinical Research, Scripps Translational Science Institute at Scripps Clinic. OpenAlex indexes 282 publications with 21,078 citations (h-index 65); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Gastroenterology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Paul Pockros, MD, is Director, Liver Disease Center, Division of Gastroenterology/Hepatology, Scripps Clinic. The public record shows 282 publications with 21,078 citations (h-index 65), centered on Viral Hepatitis (B/C). It also documents an investigator role on 3 registered clinical trials, industry payments reported by 32 companies, 1 NIH-funded awards (1987–2002).

  • Most recent indexed publication: 2023 · Hepatology communications
  • Top research focus: Viral Hepatitis (B/C)
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 32 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Cholangitis, Sclerosing1 trialCholangitis1 trialBrain Diseases1 trialHepatic Encephalopathy1 trialViral Hepatitis (B/C)1 trialHepatitis C1 trial

Research focus

OpenAlex concept fingerprint
Viral Hepatitis (B/C)

Drugs & molecules

across trials, industry payments and publications
Ocalivageneric · Obeticholic acidClinical trialsIndustry payments36Publications1Livmarligeneric · MaralixibatClinical trialsIndustry payments1Publications1Mavyretgeneric · Glecaprevir / pibrentasvirClinical trialsIndustry payments33Publications

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trialsIndustry payments86Gilead Sciences, Inc.Clinical trialsIndustry payments58Intercept Pharmaceuticals, Inc.Clinical trialsIndustry payments37

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
282publications

Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.

21,078citations

Total citations across indexed works.

65h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials
32companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 1987–2002

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

32 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    62%
    Bile Acid36.6%
    Ursodiol100%
    Part D51 patients
    Bile acids and derivatives8.4%
    Ocaliva100%
    Part D<11 patients
  • Anti-infectives

    18%
    Nucleoside and nucleotide reverse transcriptase inhibitors14.7%
    Vemlidy100%
    Part D11 patients
    Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor3.3%
    Entecavir100%
    Part D<11 patients
  • Cancer & immunology

    12.7%
    Purine Antimetabolite12.7%
    Azathioprine100%
    Part D17 patients
2 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)51% facility · 49% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

1 NIH research award on record, funded 19872002 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • ResearchGate

    researchgate.net/profile/Paul-Pockros

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • Doximity

    doximity.com/pub/paul-pockros-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/paul-pockros-780b0925

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com
1 more verified account behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Other

    vivo.scripps.edu/display/PockrosPaul

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vivo.scripps.edu
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com
1 more mention behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board Certified

    American Board of Internal Medicine, Gastroenterology

    1985
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scripps.org
  • Board Certified

    American Board of Internal Medicine

    1982
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scripps.org
  • MD

    University of Southern California School of Medicine

    1978
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scripps.org
  • Internal medicine residency

    USC School of Medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com
  • Hepatology fellowship

    Rancho Los Amigos Medical Center/School

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com

Editorial & leadership roles

journal and society appointments
  • Director of Clinical Research

    Scripps Translational Science Institute / Scripps Research Institute

    2012
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org
  • Director

    Liver Disease Center, Scripps Clinic

    1990
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org
  • Former Chief of Staff

    Scripps Green Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scripps.org
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
1 more media item behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.